1
Clinical Trials associated with KN-510An Open-label, Dose-escalation and Dose-finding, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 as Combination Therapy in Patients With Advanced Solid Tumors
To evaluate the safety and tolerability of the combination therapy of KN510 and KN713 and determine the MTD and RP2D in patients with advanced solid tumors.
100 Clinical Results associated with KN-510
100 Translational Medicine associated with KN-510
100 Patents (Medical) associated with KN-510
100 Deals associated with KN-510